Susquehanna International Group’s Catheter Precision VTAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-80
Closed -$23.4K 13245
2023
Q1
$23.4K Buy
+80
New +$43.5K ﹤0.01% 12006
2022
Q4
Sell
-9
Closed -$10K 13788
2022
Q3
$10K Buy
+9
New +$17.1K ﹤0.01% 12781
2022
Q2
Sell
-1
Closed -$6K 14046
2022
Q1
$6K Buy
+1
New +$6.8K ﹤0.01% 12805
2019
Q2
Hold
0
-$72K 10899
2019
Q1
Hold
0
8377

Other funds holding VTAK

Susquehanna International Group's VTAK Position: Q2 2023 in Review

Susquehanna International Group sold out of Catheter Precision (VTAK) in Q2 2023, closing a stake of 80 shares — an estimated $23.4K sold.

Susquehanna International Group first reported a position in VTAK in Q1 2022 and held it in 3 quarters. The position peaked at $23.4K in Q1 2023. 10 funds tracked by Wall St. Rank hold VTAK as of Q2 2023.

  • Susquehanna International Group reported no remaining Catheter Precision position as of Q2 2023 after selling out during the quarter.
  • Susquehanna International Group sold 80 Catheter Precision shares in Q2 2023, an estimated $23.4K.
  • Susquehanna International Group first reported a position in Catheter Precision in Q1 2022 and held it in 3 quarters.
  • Susquehanna International Group's Catheter Precision position peaked at $23.4K in Q1 2023.
  • 10 funds tracked by Wall St. Rank held Catheter Precision as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.